IFNγ-induced up-regulation of PD-ECGF/TP enhances the cytotoxicity of 5-fluorouracil and 5′-deoxy-5-fluorouridine in bladder cancer cells

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2607-2612

  Li, Gang ^a,b   Kawakami, Satoru ^a   Kageyama, Yukio ^a   Yan, Chunyin ^b   Saito, Kazutaka ^a   Kihara, Kazunori ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

5 deoxy 5 fluorouridine; 5 fluorouracil; Bladder cancer; Interferon gamma; Thymidine phosphorylase

Indexed keywords

CYTOKINE; DOXIFLURIDINE; DRUG METABOLITE; FLUOROURACIL; GAMMA INTERFERON; MESSENGER RNA; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INDUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IC 50; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, TRANSITIONAL CELL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME INDUCTION; FLOXURIDINE; FLUOROURACIL; HUMANS; INTERFERON TYPE II; MIDDLE AGED; MITOMYCIN; RNA, MESSENGER; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 0036765955     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989.
2. Moghaddam A and Bicknell R: Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31: 12141-12146, 1992.
3. Fujimoto J, Wang Y, Inoue K and Ogawa M: Antitumor activity of a new fluoropyrimidine derivative, 5′-deoxy-5-fluorouridine, against murine and human experimental tumors. Jpn J Cancer Res 76: 644-650, 1985.
4. Mascia L and Ipata PL: Activation pathways of 5-fluorouracil in rat organs and in PC12 cells. Biochem Pharmacol 62: 213-218, 2001.
5. Woodman PW, Sarrif AM and Heidelberger C: Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2′-deoxyuridine. Cancer Res 40: 507-511, 1980.
6. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K and Ishitsuka H: Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333-338, 1993.
7. Goto H, Kohno K, Sone S, Akiyama S, Kuwano M and Ono M: Interferon gamma-dependent induction of thymidine phosphorylase/platelet-derived endothelial growth factor through gamma-activated sequence-like element in human macrophages. Cancer Res 61: 469-473, 2001.
8. Nilsson S, Ragnhammar P, Glimelius B and Nygren P: A systematic overview of chemotherapy effects in urothelial bladder cancer. Acta Oncol 40: 371-390, 2001.
9. Hussain MH, Glass TR, Forman J, Sakr W, Smith DC, Al-Sarraf M, Jones J, Balcerzak SP, Crawford ED and Grossman HB: Combination cisplatin, 5-fluorouracil and radiation therapy for locally advanced unresectable or medically unfit bladder cancer cases: a Southwest Oncology Group Study. J Urol 165: 56-60, 2001.
10. Fukui I, Yonese J, Tsukamoto T, Yoshida T, Kim T, Tohma T and Ishiwata D: Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer. Cancer Chemother Pharmacol 48: 88-93, 2001.
11. Kubota Y, Miura T, Shuin T, Kinoshita Y, Hosaka M, Kondo I, Moriyama M, Fukushima S, Fukuoka H and Miyai K: Phase II study of 5′-DFUR (Furtulon) capsule for bladder cancer. Gan To Kagaku Ryoho 18: 2301-2306, 1991.
12. Endo M, Shinbori N, Fukase Y, Sawada N, Ishikawa T, Ishitsuka H and Tanaka Y: Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5′-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models. Int J Cancer 83: 127-134, 1999.
13. Ishii R, Takiguchi N, Oda K, Koda K and Miyazaki M: Thymidine phosphorylase expression is useful in selecting adjuvant chemotherapy for stage III gastric cancer. Int J Oncol 19: 717-722, 2001.
14. Hermanek P and Sobin LH: TNM Classification of Malignant Tumours, 4th edn, 2nd revision. Berlin: Springer-Verlag, 1992, pp274-9.
15. Mostofi MK, Sobin LH and Torioni H: Histological Typing of Urinary Bladder Tumors No. 10. Geneva: World Health Organization, 1973.
16. Kawakami S, Kageyama Y, Fujii Y, Kihara K and Oshima H: Inhibitory effect of N-acetylcysteine on invasion and MMP-9 production of T24 human bladder cancer cells. Anticancer Res 21: 213-219, 2001.
17. Xia G, Kageyama Y, Hayashi T, Kawakami S, Yoshida M and Kihara K: Regulation of vascular endothelial growth factor transcription by endothelial PAS domain protein 1 (EPAS1) and possible involvement of EPAS1 in the angiogenesis of renal cell carcinoma. Cancer 91: 1429-1436, 2001.
18. Makower D, Wadler S, Haynes H and Schwartz EL: Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo. Clin Cancer Res 3: 923-929, 1997.
19. Zhang L, Mackenzie IZ, Rees MC and Bicknell R: Regulation of the expression of the angiogenic enzyme platelet-derived endothelial cell growth factor/thymidine phosphorylase in endometrial isolates by ovarian steroids and cytokines. Endocrinology 138: 4921-4930, 1997.
20. Martinussen J and Hammer K: Cloning and characterization of upp, a gene encoding uracil phosphoribosyltransferase from Lactococcus lactis. J Bacteriol 176: 6457-6463, 1994.
21. Chung YM, Park S, Park JK, Kim Y, Kang Y and Yoo YD: Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells. Cancer Lett 159: 95-101, 2000.
22. Chu E, Lai GM, Zinn S and Allegra CJ: Resistance of a human ovarian cancer line to 5-fluorouracil associated with decreased levels of 5-fluorouracil in DNA. Mol Pharmacol 38: 410-417, 1990.
23. Schwartz EL, Baptiste N, Wadler S and Makower D: Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J Biol Chem 270: 19073-19077, 1995.
24. Morita T, Matsuzaki A and Tokue A: Enhancement of sensitivity to capecitabine in human renal carcinoma cells transfected with thymidine phosphorylase cDNA. Int J Cancer 92: 451-456, 2001.
25. Moghaddam A, Zhang HT, Fan TP, Hu DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL and Bicknell R: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92: 998-1002, 1995.
26. Evrard A, Cuq P, Robert B, Vian L, Pelegrin A and Cano JP: Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: in vitro and in vivo study. Int J Cancer 80: 465-470, 1999.
27. Stavropoulos NE, Ioachim E, Pappa L, Hastazeris K and Agnantis NJ: Antiproliferative activity of interferon gamma in superficial bladder cancer. Anticancer Res 19: 4529-4533, 1999.